Medplus Health Services Ltd

BSE :543427 NSE :MEDPLUS Sector : Retail
819.50
Change: 10.75(1.33%)
52 week Low
616.00
52 week High
875.65
Day low
811.45
Day high
823.65
Prev Close
808.75
Open
820.00
6M return
21.28%
1Y return
18.91%
MCap(Rs. in Cr.)
9,680.24
Total Volume
43,651
Face Value : 2
Listed Since 23 Dec 2021
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
73.07866
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
11.06
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
5.99
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
65.3%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
820.55
Resistance 2
832.35
Support 1
795.30
Support 2
781.85

Moving Average

20 Days
755.60
50 Days
743.08
100 Days
775.03
200 Days
725.11
Growth in 3 years

Sales
48.83%

Sales Industry Avg
25.81%

PAT
-30.76%

PAT Industry Avg
169.74%

Dec 2024
( in Cr.)
Sep 2024
( in Cr.)
Jun 2024
( in Cr.)
Mar 2024
( in Cr.)
FY 2024
( in Cr.)
Sales1,561.451,576.171,488.831,490.505,624.86
Gross Profit119.07110.9277.8291.20297.66
Operating Profit00000
Profit Before Tax61.3952.4020.3842.2473.44
Tax15.5213.706.048.687.86
Profit After Tax45.8738.7014.3433.5665.58
Growth in 3 years

Total Asset Growth
16.97%

Total Liabilities growth
15.89%

Reserves Change
11.49%

Mar 2024
( in Cr.)
Mar 2023
( in Cr.)
Mar 2022
( in Cr.)
Mar 2021
( in Cr.)
Mar 2020
( in Cr.)
Share Capital23.9123.8623.860.450.19
Reserves And Surplus1,554.031,467.321,393.91730.11527.61
Investments00.030.030.030.25
Total Debt1,009.57899.92814.93590.22477.29
Total Liabilities2,586.942,390.422,232.181,321.331,006.39
Total Assets2,5212,332.132,155.271,259.71957.19
No data available


Relative to Sensex rtn in 3 year
-144.95%

Relative to Nifty rtn in 3 year
-143.31%



1 Year (%)2 Year (%)3 Year (%)
Medplus Health1912-18
Bse Sensex83339
Nifty 5083641
Nifty Microcap 25079999

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Medplus Health
819.50
Change: 10.75 (1.33%)
1 Year return
18.91%
Risk (Std Dev)
0.07%
PE Ratio
73.07866
MCap( in Cr.)
9,680.24
Avenue Super.
4,455.00
Change: 19.40 (0.44%)
1 Year return
-6.37%
Risk (Std Dev)
0.11%
PE Ratio
106.09569
MCap( in Cr.)
2,88,639.16
Trent
5,278.50
Change: -44.50 (-0.84%)
1 Year return
26.63%
Risk (Std Dev)
0.13%
PE Ratio
127.27099
MCap( in Cr.)
1,89,225.98
Aditya Bir. Fas.
271.65
Change: -0.30 (-0.11%)
1 Year return
12.83%
Risk (Std Dev)
0.12%
PE Ratio
NM
MCap( in Cr.)
33,184.23
Redtape
141.73
Change: -2.16 (-1.50%)
1 Year return
-19.35%
Risk (Std Dev)
0.14%
PE Ratio
46.85668
MCap( in Cr.)
7,954.35
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 1,18,914.60 with a Gain of 18.91%

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

Institutional Reports 11 Apr 2025 4:18 PM
The India Pharma & Healthcare sector is expected to see steady growth and margin improvement during Q4FY25E. We project sales/EBITDA growth of 13%/19% YoY for our coverage universe. Our assumptions a..
Institutional Reports 03 Apr 2025 12:14 PM
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India. However, pharmaceutical products were exempted from the first round o..
Institutional Reports 04 Feb 2025 7:10 AM
ONGC: We maintain our REDUCE rating on ONGC, with a revised target price of INR 245, given: (1) limited upside potential for ONGC’s crude price realisation in the current environment, (2) gas price r..
View More

News

Stay tuned to the latest developments and happenings in the company.

Medplus Health Services schedules board meeting

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live News....

26 Mar 2025 09:20

Medplus Health Services consolidated net profit rises 234.23% in the December 2024 quarter

Net profit of Medplus Health Services rose 234.23% to Rs 45.89 crore in the quarter ended December 2024 as against Rs 13.73 crore during the previous ....

01 Feb 2025 07:43

Medplus Health Services to discuss results

Medplus Health Services will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live ....

09 Jan 2025 10:22

MedPlus Health Services allots 1.46 lakh equity shares under ESOP

MedPlus Health Services has allotted 1,46,675 equity shares under ESOP on 18 December 2024. With this allotment, the paid up equity share capital has ....

18 Dec 2024 17:42

Medplus Health Services consolidated net profit rises 166.07% in the September 2024 quarter

Net profit of Medplus Health Services rose 166.07% to Rs 38.74 crore in the quarter ended September 2024 as against Rs 14.56 crore during the previous....

12 Nov 2024 17:22

Medplus Health Services consolidated net profit rises 278.89% in the June 2024 quarter

Net profit of Medplus Health Services rose 278.89% to Rs 14.36 crore in the quarter ended June 2024 as against Rs 3.79 crore during the previous quart....

03 Aug 2024 07:34

View More
Subscribe for our
newsletter
Open Account Now